Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06011577
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2023-08-21
Brief Title:
Randomized Double-Blind Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Sponsor:
Organization:
Relmada Therapeutics Inc